Isracann Biosciences Cash from Financing (TTM) Analysis

Isracann Biosciences Inc (ISCNF)

0.0001 0.00 (0.00%) USD | OTCM | Apr 22, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
August 31, 2022	0.2205M
May 31, 2022	0.103M
February 28, 2022	0.6447M
November 30, 2021	1.628M
August 31, 2021	1.451M
May 31, 2021	1.674M
February 28, 2021	0.9819M
November 30, 2020	1.398M
August 31, 2020	9.751M
May 31, 2020	9.528M
February 29, 2020	9.576M
November 30, 2019	8.176M
August 31, 2019	0.00
May 31, 2019
February 28, 2019
November 30, 2018
August 31, 2018
May 31, 2018
February 28, 2018
November 30, 2017
August 31, 2017
May 31, 2017	0.5711M
February 28, 2017	0.5727M

Date	Value
November 30, 2016	0.6207M
August 31, 2016	0.7821M
May 31, 2016	0.1397M
February 29, 2016	0.1709M
November 30, 2015	0.1311M
August 31, 2015	-0.033M
May 31, 2015	0.5109M
February 28, 2015	0.4835M
November 30, 2014	0.5195M
August 31, 2014	0.5358M
May 31, 2014	0.00
February 28, 2014	-0.0003M
November 30, 2013	-0.0006M
August 31, 2013	0.0336M
May 31, 2013
February 28, 2013
November 30, 2012
August 31, 2012
May 31, 2012	0.00
February 29, 2012	-0.0092M
November 30, 2011	-0.0133M
August 31, 2011	0.3478M
May 31, 2011	0.3021M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Aug 2019

9.751M

Maximum

Aug 2020

3.472M

Average

1.451M

Median

Aug 2021

Cash from Financing (TTM) Benchmarks